IL95412A - Pharmaceutical preparation for the treatment of eye diseases containing 5-methyl-oxazole-4-carboxylic acid anilides and cyanoacetic acid 2-hydroxyethylidine anilides - Google Patents
Pharmaceutical preparation for the treatment of eye diseases containing 5-methyl-oxazole-4-carboxylic acid anilides and cyanoacetic acid 2-hydroxyethylidine anilidesInfo
- Publication number
- IL95412A IL95412A IL9541290A IL9541290A IL95412A IL 95412 A IL95412 A IL 95412A IL 9541290 A IL9541290 A IL 9541290A IL 9541290 A IL9541290 A IL 9541290A IL 95412 A IL95412 A IL 95412A
- Authority
- IL
- Israel
- Prior art keywords
- carbon atoms
- group
- compound
- bromine
- chlorine
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/42—Oxazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/275—Nitriles; Isonitriles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/14—Decongestants or antiallergics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Ophthalmology & Optometry (AREA)
- Immunology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Medicinal Preparation (AREA)
- Plural Heterocyclic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US39586089A | 1989-08-18 | 1989-08-18 |
Publications (2)
Publication Number | Publication Date |
---|---|
IL95412A0 IL95412A0 (en) | 1991-06-30 |
IL95412A true IL95412A (en) | 1996-01-31 |
Family
ID=23564835
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IL9541290A IL95412A (en) | 1989-08-18 | 1990-08-17 | Pharmaceutical preparation for the treatment of eye diseases containing 5-methyl-oxazole-4-carboxylic acid anilides and cyanoacetic acid 2-hydroxyethylidine anilides |
Country Status (15)
Country | Link |
---|---|
EP (1) | EP0413329B1 (ja) |
JP (1) | JP3131693B2 (ja) |
KR (1) | KR100192745B1 (ja) |
AT (1) | ATE148628T1 (ja) |
AU (1) | AU633346B2 (ja) |
CA (1) | CA2023560C (ja) |
DD (1) | DD297328A5 (ja) |
DE (1) | DE69029884T2 (ja) |
DK (1) | DK0413329T3 (ja) |
ES (1) | ES2099700T3 (ja) |
HU (1) | HU215959B (ja) |
IE (1) | IE902978A1 (ja) |
IL (1) | IL95412A (ja) |
TW (1) | TW287948B (ja) |
ZA (1) | ZA906544B (ja) |
Families Citing this family (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ATE128353T1 (de) * | 1991-10-23 | 1995-10-15 | Hoechst Ag | N-phenyl-2-cyano-3-hydroxycrotonsäureamidderiva e und deren verwendung als arzneimittel mit immunmodulatorischer eigenschaft. |
TW314467B (ja) * | 1993-03-31 | 1997-09-01 | Hoechst Ag | |
US6335356B1 (en) | 1994-01-07 | 2002-01-01 | Sugen, Inc. | Method of treating a patient by parenteral administration of a lipophilic compound |
US5700823A (en) * | 1994-01-07 | 1997-12-23 | Sugen, Inc. | Treatment of platelet derived growth factor related disorders such as cancers |
US5610173A (en) * | 1994-01-07 | 1997-03-11 | Sugen, Inc. | Formulations for lipophilic compounds |
ATE194912T1 (de) * | 1994-10-17 | 2000-08-15 | Aventis Pharma Ltd | Mittel zur vorsorge und heilung von typ i allergischen krankheiten |
US5721277A (en) * | 1995-04-21 | 1998-02-24 | Sugen, Inc. | Compounds and methods for inhibiting hyper-proliferative cell growth |
US6331555B1 (en) | 1995-06-01 | 2001-12-18 | University Of California | Treatment of platelet derived growth factor related disorders such as cancers |
US6011051A (en) * | 1996-07-31 | 2000-01-04 | Hoechst Aktiengesellschaft | Use of isoxazole and crotonamide derivatives for the modulation of apoptosis |
US6316479B1 (en) | 1997-05-19 | 2001-11-13 | Sugen, Inc. | Isoxazole-4-carboxamide compounds active against protein tryosine kinase related disorders |
DE102006017896A1 (de) † | 2006-04-13 | 2007-10-25 | Tiefenbacher Pharmachemikalien Alfred E. Tiefenbacher Gmbh & Co. Kg | Leflunomid enthaltende pharmazeutische Zusammensetzungen |
AU2015257651B2 (en) * | 2014-05-08 | 2020-01-23 | Panoptes Pharma Ges.M.B.H. | Compounds for treating ophthalmic diseases and disorders |
KR20230140410A (ko) * | 2022-03-25 | 2023-10-06 | 바스테라 주식회사 | 3-페닐이속사졸 유도체 및 이를 유효성분으로 함유하는 안질환 예방 또는 치료용 약학 조성물 |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
NL186239B (nl) * | 1975-06-05 | Hoechst Ag | Werkwijze voor de bereiding van een geneesmiddel met antiflogistische en/of analgetische werking, alsmede werkwijze voor de bereiding van een 2-hydroxyethylideencyaanazijnzuuranilide geschikt voor toepassing bij deze werkwijze. | |
ES448386A1 (es) | 1975-06-05 | 1978-04-16 | Hoechst Ag | Procedimiento para la preparacion de anilidas de acido 5-me-til-isoxazol-4-carboxilico. |
DE2854439A1 (de) * | 1978-12-16 | 1980-07-03 | Hoechst Ag | Ein isoxazolderivat, verfahren zu seiner herstellung, diese verbindung enthaltende mittel und verwendung |
DE3534440A1 (de) * | 1985-09-27 | 1987-04-02 | Hoechst Ag | Arzneimittel gegen chronische graft-versus-host-krankheiten sowie gegen autoimmunerkrankungen, insbesondere systemischen lupus erythematodes |
GB8619432D0 (en) * | 1986-08-08 | 1986-09-17 | Lilly Industries Ltd | Pharmaceutical compounds |
-
1990
- 1990-08-15 DD DD90343461A patent/DD297328A5/de unknown
- 1990-08-16 ES ES90115691T patent/ES2099700T3/es not_active Expired - Lifetime
- 1990-08-16 AT AT90115691T patent/ATE148628T1/de not_active IP Right Cessation
- 1990-08-16 JP JP02215129A patent/JP3131693B2/ja not_active Expired - Fee Related
- 1990-08-16 EP EP90115691A patent/EP0413329B1/en not_active Expired - Lifetime
- 1990-08-16 KR KR1019900012602A patent/KR100192745B1/ko not_active IP Right Cessation
- 1990-08-16 DE DE69029884T patent/DE69029884T2/de not_active Expired - Fee Related
- 1990-08-16 DK DK90115691.9T patent/DK0413329T3/da active
- 1990-08-17 AU AU61104/90A patent/AU633346B2/en not_active Ceased
- 1990-08-17 IL IL9541290A patent/IL95412A/en not_active IP Right Cessation
- 1990-08-17 TW TW081106491A patent/TW287948B/zh active
- 1990-08-17 IE IE297890A patent/IE902978A1/en not_active IP Right Cessation
- 1990-08-17 ZA ZA906544A patent/ZA906544B/xx unknown
- 1990-08-17 CA CA002023560A patent/CA2023560C/en not_active Expired - Fee Related
- 1990-08-17 HU HU905064A patent/HU215959B/hu not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
EP0413329A2 (en) | 1991-02-20 |
DD297328A5 (de) | 1992-01-09 |
DE69029884D1 (de) | 1997-03-20 |
DE69029884T2 (de) | 1997-08-14 |
IL95412A0 (en) | 1991-06-30 |
CA2023560A1 (en) | 1991-02-19 |
ATE148628T1 (de) | 1997-02-15 |
AU6110490A (en) | 1991-02-21 |
KR100192745B1 (ko) | 1999-06-15 |
JP3131693B2 (ja) | 2001-02-05 |
TW287948B (ja) | 1996-10-11 |
HU215959B (hu) | 1999-03-29 |
HU905064D0 (en) | 1991-01-28 |
HUT59600A (en) | 1992-06-29 |
AU633346B2 (en) | 1993-01-28 |
EP0413329B1 (en) | 1997-02-05 |
EP0413329A3 (en) | 1992-04-15 |
CA2023560C (en) | 2000-12-12 |
ZA906544B (en) | 1991-06-26 |
KR910004193A (ko) | 1991-03-28 |
IE902978A1 (en) | 1991-02-27 |
DK0413329T3 (da) | 1997-08-18 |
ES2099700T3 (es) | 1997-06-01 |
JPH0390024A (ja) | 1991-04-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US5677335A (en) | 5-methyl-isoxazole-4-carboxylic acid anilides and 2-hydroxyethylidene-cyano acetic acid anilides for the treatment of ocular disease | |
EP0413329B1 (en) | 5-Methyl-isoxazole-4-carboxylic acid anilides and 2-hydroxyethylidene-cyano acetic acid anilides for the treatment of ocular diseases | |
AU784017B2 (en) | Solutions containing epinastine | |
US5180721A (en) | Combinations of selective alpha-adrenergic agonists and antagonists useful in lowering intraocular pressure | |
US5281591A (en) | Combinations of selective alpha-adrenergic agonists and antagonists useful in lowering intraocular pressure | |
US5021410A (en) | Combinations of selective alpha-adrenergic agonists and antagonists useful in lowering intraocular pressure | |
EP0743852A1 (en) | Treatment of normotensive glaucoma with angiotensin ii antagonists | |
US20080161389A1 (en) | Method of treating ocular hypertension and intestinal disorders by using dianhydrohexite mononitrate derivatives | |
US6646003B2 (en) | Method of treating ocular inflammatory and angiogenesis-related disorders of the posterior segment of the eye using an amide derivative of flurbiprofen or ketorolac | |
US20050009902A1 (en) | Remedies for pruritus | |
EP1701700A1 (en) | Compositions comprising memantine and polyanionic polymers for administration to the eye | |
WO1993015732A1 (en) | Treatment of glaucoma | |
JPH0525167A (ja) | 緑内障の治療に有用な置換ベンゼン誘導体 | |
US5428030A (en) | Method of reducing elevated intraocular pressure | |
JPH0778022B2 (ja) | 緑内障治療剤 | |
JPH0797318A (ja) | オキシフェドリンを必須成分とする眼圧降下剤 | |
FR2648042A1 (fr) | Utilisation de phenylethanolaminotetralines pour la preparation de medicaments pour le traitement des affections oculaires | |
JPH02218612A (ja) | 緑内障の治療におけるアンギオテンシン変換酵素阻害剤 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FF | Patent granted | ||
KB | Patent renewed | ||
KB | Patent renewed | ||
MM9K | Patent not in force due to non-payment of renewal fees |